Los Angeles Capital Management LLC Sells 25,021 Shares of Humana Inc. (NYSE:HUM)

Los Angeles Capital Management LLC cut its stake in Humana Inc. (NYSE:HUM) by 97.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 604 shares of the insurance provider’s stock after selling 25,021 shares during the period. Los Angeles Capital Management LLC’s holdings in Humana were worth $226,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HUM. Avantax Advisory Services Inc. grew its holdings in shares of Humana by 12.2% in the fourth quarter. Avantax Advisory Services Inc. now owns 2,446 shares of the insurance provider’s stock worth $1,120,000 after purchasing an additional 265 shares during the last quarter. Janney Montgomery Scott LLC grew its holdings in Humana by 8.1% during the 4th quarter. Janney Montgomery Scott LLC now owns 7,970 shares of the insurance provider’s stock worth $3,649,000 after acquiring an additional 594 shares in the last quarter. Brown Advisory Inc. grew its holdings in Humana by 17.9% during the 4th quarter. Brown Advisory Inc. now owns 2,724 shares of the insurance provider’s stock worth $1,247,000 after acquiring an additional 413 shares in the last quarter. Norges Bank bought a new position in Humana during the 4th quarter worth about $676,800,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Humana during the 4th quarter worth about $1,062,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HUM has been the topic of several recent research reports. JPMorgan Chase & Co. increased their target price on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 price target on shares of Humana in a research report on Tuesday, September 10th. TD Cowen increased their price target on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Royal Bank of Canada increased their price target on shares of Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, September 5th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Thirteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus target price of $398.70.

Humana Price Performance

Shares of NYSE HUM opened at $321.56 on Monday. The stock has a market capitalization of $38.72 billion, a price-to-earnings ratio of 20.02, a PEG ratio of 2.56 and a beta of 0.50. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The firm’s 50 day simple moving average is $364.11 and its 200-day simple moving average is $346.85. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $8.94 EPS. Analysts expect that Humana Inc. will post 16 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a yield of 1.10%. Humana’s dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.